Literature DB >> 871129

Concurrent hypercortisolism and hypermineralocorticoidism.

M J Hogan, M Schambelan, E G Biglieri.   

Abstract

Hypertension and hypokalemia occur in patients with Cushing's syndrome whereas aldosterone production is normal and plasma renin activity is usually normal or increased. A normal aldosterone level in the face of suppressed plasma renin activity is unusual and suggests excess mineralocorticoid hormone activity. Our patient, who had Cushing's syndrome due to adrenocortical adenoma, can be classified as having low renin hypertension (suppressed renin and normal aldosterone levels). The mineralocorticoid hormone in excess was deoxycorticosterone which suppressed renin. The aldosterone production was normal and was produced solely by the adenoma. Contralateral adrenal gland suppression of both the zona glomerulosa by deoxycorticosterone via renin, and of the fasciculata by cortisol via ACTH was demonstrated after removal of the adenoma. Normal adrenal function was gradually restored.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871129     DOI: 10.1016/0002-9343(77)90883-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

2.  Malignant hypertension and asymmetric septal hypertrophy in a 43-year-old black man.

Authors:  J C Rutledge; A Eng; J Silva
Journal:  West J Med       Date:  1986-09

3.  11-Deoxycorticosterone Producing Adrenal Hyperplasia as a Very Unusual Cause of Endocrine Hypertension: Case Report and Systematic Review of the Literature.

Authors:  Queralt Asla; Helena Sardà; Enrique Lerma; Felicia A Hanzu; María Teresa Rodrigo; Eulàlia Urgell; José Ignacio Pérez; Susan M Webb; Anna Aulinas
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

Review 4.  The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.

Authors:  Gian Paolo Rossi; Valeria Bisogni; Alessandra Violet Bacca; Anna Belfiore; Maurizio Cesari; Antonio Concistrè; Rita Del Pinto; Bruno Fabris; Francesco Fallo; Cristiano Fava; Claudio Ferri; Gilberta Giacchetti; Guido Grassi; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Giuseppe Maiolino; Dario Manfellotto; Pietro Minuz; Silvia Monticone; Alberto Morganti; Maria Lorenza Muiesan; Paolo Mulatero; Aurelio Negro; Gianfranco Parati; Martino F Pengo; Luigi Petramala; Francesca Pizzolo; Damiano Rizzoni; Giacomo Rossitto; Franco Veglio; Teresa Maria Seccia
Journal:  Int J Cardiol Hypertens       Date:  2020-04-15

5.  Hypertension with unilateral adrenal aldosterone and cortisol cosecreting adenoma: A case report.

Authors:  Zhe Hu; Xin Chen; Yuan Shao; Fang-Xiu Luo; Shao-Li Chu; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-10-17       Impact factor: 3.738

6.  Two cases of aldosterone and cortisol producing adenoma with different histopathological features: A case report.

Authors:  Hongjiao Gao; Li Li; Haoming Tian
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.